While once thought to be rare, recent data published by Lee and colleagues suggest the incidence of venous thromboembolism (eg, deep vein thrombosis or pulmonary embolism) is on the rise in India, accounting for about 17.5 per 10,000 hospital admissions. Unfortunately, approximately 20% of patients experiencing an unprovoked venous thromboembolism…
Read more »
mdCurrent Conference Report: American College of Cardiology’s 61st Annual Scientific Session & Expo A new study looking at an all-oral medication regimen for treating pulmonary embolism (PE) finds it as effective as starting with injectable enoxaparin and then switching to warfarin. The one-agent regimen would permit most of the treatment…
Read more »
Algorithms that predict risk for venous thromboembolism occurring outside of the hospital setting should be reevaluated to include infection, erythropoiesis-stimulating agents, and blood transfusion, in addition to the more commonly recognized triggers such as major surgeries, fractures, immobility, and chemotherapy, according to a recent study. “The notion that VTE occurs…
Read more »
indicates a Peer-Reviewed Article
Menopausal hormone replacement therapy reduces fractures but increases risks for other conditions
A great deal of controversy surrounds the use of menopausal hormone replacement therapy (HRT) for the prevention of chronic conditions. “There are robust data now coming in that there is a window of opportunity in the early menopausal years when HRT may reduce the risk of cardiovascular disease. It would…
Read more »